ipilimumab,nivolumab
bms
['titan-rcc', 'rcc,(-irccs),(-srcc),(-urcc)', 'nivo']
immuno-therapeutic boost in mrcc final results of titan-rcc: boosting significantly improved orr but inferior to upfront nivo-ipi #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni